Seminars in Hematology
Volume 46, Supplement 3 , Pages S11-S15, April 2009

Clinical Strategies to Achieve an Early and Successful Response to Tyrosine Kinase Inhibitor Therapy

  • Timothy Hughes

      Affiliations

    • Division of Haematology, Institute of Medical and Veterinary Science, Adelaide, Australia
    • Corresponding Author InformationAddress correspondence to Timothy Hughes, MD, Deputy Head, Division of Haematology, Institute of Medical and Veterinary Science, Frome Road, Adelaide, SA, 5000, Australia
    • ,
  • Andreas Hochhaus

      Affiliations

    • Abteilung Leukämieforschung, III Medizinische Klinik, Universitätsmedizin Mannheim, Universität Heidelberg, Mannheim, Germany

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 CONFLICT OF INTEREST STATEMENT: Dr Hughes has no conflicts of interest to disclose. Dr Hochhaus has received research support and honoraria for presentations and advisory boards from Novartis Pharmaceuticals Corp.

 Editorial support was provided by Daniel Hutta (Health Interactions) on behalf of Novartis Oncology. A.H. was supported by the German José-Carreras Foundation (DJCLS H 03/01). T.H. is a Practitioner Fellow of the National Health and Medical Council of Australia.

PII: S0037-1963(09)00019-5

doi:10.1053/j.seminhematol.2009.01.008

Seminars in Hematology
Volume 46, Supplement 3 , Pages S11-S15, April 2009

Article Tools

* Image Usage & Resolution